How would you modify adjuvant therapy for a patient with ER+ HER2+ breast CA with no response to neoadjuvant TCHP and develops pneumonitis on adjuvant TDM-1?
1
1 Answers
Mednet Member
Medical Oncology · Northwestern Medicine Cancer Center at KishHealth
Retest tissue for Her2.
No data for cytotoxic chemo but consider ACx4 and adjuvant Traz/pertuz to complete a year and then perhaps Neratinib especially if ER+ive.
